InspireMD Inc NSPR

NAS: NSPR | ISIN: US45779A8466 30/04/2025

2,540 USD (+3,53%)

(+3,53%) 30/04/2025

Grafiek InspireMD Inc

Grafiek InspireMD Inc

1 dag1d 3,53%
1 week1w -2,31%
1 maand1m 0,20%
3 maanden3m 1,60%
6 maanden6m 2,42%
1 jaar1j 30,02%
5 jaar5j 247,95%

vrijdag 9 mei 2025, 13:00

Kwartaalcijfers (1ste kwartaal)

InspireMD Inc in het nieuws

Toon enkel gratis nieuws

9 maart 2021 · InspireMD Announces Fourth Quarter and Year-End 2020 Financial Results · Persbericht

2 maart 2021 · InspireMD to Report Fourth Quarter and Year-End 2020 Financial Results on Tuesday, March 9, 2021 and Provide Corporate Update · Persbericht

24 februari 2021 · InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United States · Persbericht

9 februari 2021 · InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States · Persbericht

8 februari 2021 · InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option · Persbericht

4 februari 2021 · InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering · Persbericht

3 februari 2021 · InspireMD Secures Partner for Intended Registration and Distribution of CGuard EPS in Mainland China · Persbericht

26 januari 2021 · InspireMD’s CGuard™ Featured in Multiple Presentations, Including a Live Case Demonstration During the Leipzig Interventional Congress January 25-29, 2021 · Persbericht

Profiel InspireMD Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

CEO: Marvin Slosman

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe